Anita Wagner

Anita Katharina Wagner, PharmD, MPH, DrPH

Fellow in Bioethics

Anita Katharina Wagner is Associate Professor in the Division of Health Policy and Insurance Research at the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute. She also serves as the Director of the Harvard Pilgrim Health Care Ethics Program

Dr. Wagner conducts empirical research generating evidence for answering challenging health system questions.  Her work, frequently in large databases, evaluates impacts of insurance and other policy changes on the availability, access to, affordability, and use of medicines, specifically new cancer medicines, in the United States, China, and elsewhere.    

Through the Medicines and Insurance Coverage (MedIC) Initiative she founded, Dr. Wagner has led training programs, including the first online course, to strengthen capacity of professionals in more than 20 low and middle income country health systems to design, implement, monitor and evaluate medicines policies and programs in the context of expanding health insurance coverage.

Dr. Wagner co-directs the Harvard Medical School Fellowship in Health Policy and Insurance Research and the Department of Population Medicine Center for Cancer Policy and Program Evaluation (CarPE)

Serving as a pharmacoepidemiologist on the FDA’s Sentinel Initiative, Dr. Wagner contributes to a national system that tracks the safety of pharmaceuticals in the United States. 

Dr. Wagner holds a German master-equivalent degree in pharmacy, a doctorate in clinical pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences, a Master of Public Health degree in international health and a Doctor of Public Health degree in epidemiology from the Harvard School of Public Health. She completed training programs in bioethics including the Harvard Medical School Fellowship in Bioethics.

Publications View
Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: an interrupted time series study.
Authors: Authors: Hsu JC, Lu CY, Wagner AK, Chan KA, Lai MS, Ross-Degnan D.
Health Policy
View full abstract on Pubmed
Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
Authors: Authors: Fang Y, Wagner AK, Yang S, Jiang M, Zhang F, Ross-Degnan D.
Lancet Glob Health
View full abstract on Pubmed
Health care payments in the Asia Pacific: validation of five survey measures of economic burden.
Authors: Authors: Reddy SR, Ross-Degnan D, Zaslavsky AM, Soumerai SB, Wagner AK.
Int J Equity Health
View full abstract on Pubmed
Need for and access to health care and medicines: are there gender inequities?
Authors: Authors: Wagner AK, Graves AJ, Fan Z, Walker S, Zhang F, Ross-Degnan D.
PLoS One
View full abstract on Pubmed
Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study.
Authors: Authors: Garabedian LF, Ross-Degnan D, Ratanawijitrasin S, Stephens P, Wagner AK.
BMJ Open
View full abstract on Pubmed
Simulation-based power calculation for designing interrupted time series analyses of health policy interventions.
Authors: Authors: Zhang F, Wagner AK, Ross-Degnan D.
J Clin Epidemiol
View full abstract on Pubmed
Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer.
Authors: Authors: Nekhlyudov L, Li L, Ross-Degnan D, Wagner AK.
Breast Cancer Res Treat
View full abstract on Pubmed
Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey.
Authors: Authors: Wagner AK, Graves AJ, Reiss SK, Lecates R, Zhang F, Ross-Degnan D.
Health Policy
View full abstract on Pubmed
Out-of-pocket burden of health care spending and the adequacy of the Medicare Part D low-income subsidy.
Authors: Authors: Briesacher BA, Ross-Degnan D, Wagner AK, Fouayzi H, Zhang F, Gurwitz JH, Soumerai SB.
Med Care
View full abstract on Pubmed
Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators.
Authors: Authors: Ross-Degnan D, Pierre-Jacques M, Zhang F, Tadeg H, Gitau L, Ntaganira J, Balikuddembe R, Chalker J, Wagner AK.
BMC Health Serv Res
View full abstract on Pubmed

Address: 
Harvard Pilgrim Health Care Institute
Landmark Center
401 Park Dr
Boston, MA 02215